Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunological effects of radiotherapy with or without cisplatin in HPV-positive head and neck squamous cell carcinoma
NL-OMON40292Recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of cisplatin in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Netherlands Cancer Institute. Primary endpoint: Systemic immune and T-cell changes over time. Started Apr 2015; status: recruiting.
02
Drugs
cisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NL-OMON40292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40292.